TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24372795

Group type: EXPERIMENTAL
Intervention: Accessibility-enhanced multimedia informational education
Number of subjects: 123

Group type: COMPARATOR
Intervention: Regular education
Number of subjects: 123

Group type: COMPARATOR
Intervention: Instructional digital videodisc education
Number of subjects: 123
Study: 23203206

Group type: EXPERIMENTAL
Intervention: Modified shoes
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control shoes
Number of subjects: 90

Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 90
Study: 22003158

Group type: EXPERIMENTAL
Intervention: Task-oriented, motor sequence learning exercise (TO)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Impairment-oriented, multicomponent exercise (IO)
Number of subjects: 47
Study: 18433678

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (group US)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Nerve stimulation (group NS)
Number of subjects: 74
Study: 16931259

Group type: EXPERIMENTAL
Intervention: Trypan blue 0.0125% solution (Group 1, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No anterior capsule staining (Group 2, n = 20)
Number of subjects: 40
Study: 12971634

Group type: EXPERIMENTAL
Intervention: Chemotherapy (ChT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Higher 201Tl ratios
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Delayed 201Tl uptake
Number of subjects: 23
Study: 10870068

Group type: EXPERIMENTAL
Intervention: Multilayer bandaging followed by elastic hosiery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hosiery alone
Number of subjects: 90
Study: 9090608

Group type: EXPERIMENTAL
Intervention: Kinematic MRI examination using a special device for incremental passive positioning of the ankle.
Number of subjects: 12
Study: 8257196

Group type: EXPERIMENTAL
Intervention: Structured cognitive‐behavioral group intervention
Number of subjects: 3

Group type: COMPARATOR
Intervention: Support group
Number of subjects: 3

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 3
Study: 7107688

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 201

Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 201
Study: 31794610

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 0
Study: 29350775

Group type: EXPERIMENTAL
Intervention: tDCS (1mA, 20 minutes)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 60
Study: 26832736

Group type: EXPERIMENTAL
Intervention: KiVa plus usual provision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual provision only
Number of subjects: 0
Study: 24845173

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22916226

Group type: EXPERIMENTAL
Intervention: Closantel treatment at dry-off
Number of subjects: 402
Study: 19147504

Group type: EXPERIMENTAL
Intervention: HSA+serum substitute supplement (SSS)
Number of subjects: 528

Group type: COMPARATOR
Intervention: HSA (as the sole protein supplement)
Number of subjects: 528
Study: 17971178

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (<= 40 g carbohydrate/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy-eating diet following Diabetes UK nutritional recommendations
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy-eating diet
Number of subjects: 26
Study: 16792539

Group type: EXPERIMENTAL
Intervention: PEG‐I alpha‐2b 1.0 microg/kg BW
Number of subjects: 227
Study: 15609594

Group type: EXPERIMENTAL
Intervention: Xuefu Zhuyu decoction (XZD) with conventional liver protective treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional liver protective treatment alone
Number of subjects: 60
Study: 10391548

Group type: COMPARATOR
Intervention: Conventional cementing technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bone-vacuum cementing technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No cement fixation
Number of subjects: 60
Study: 8895147

Group type: EXPERIMENTAL
Intervention: DP-1904 (400 mg/day bid)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Indomethacin (50 mg/day bid)
Number of subjects: 8
Study: 1806334

Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate 300 mcg/day
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 6354522

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) infusion during low sodium intake (10 mmol)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) infusion during high sodium intake (200 mmol)
Number of subjects: 8
Study: 30610213

Group type: EXPERIMENTAL
Intervention: 1500 mg curcumin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 28662296

Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 26134371

Group type: EXPERIMENTAL
Intervention: Doxycycline therapy
Number of subjects: 106
Study: 23630185

Group type: EXPERIMENTAL
Intervention: 50% expectancy of receiving levodopa
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 100% expectancy of receiving levodopa
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 0% expectancy of receiving levodopa
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo levodopa (all subjects)
Number of subjects: 26
Study: 21725634

Group type: EXPERIMENTAL
Intervention: 100 mg flurbiprofen axetil preoperative, 10 μg/kg fentanyl + 100 mg flurbiprofen axetil postoperative (Group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 100 mg flurbiprofen axetil preoperative, 10 μg/kg fentanyl + 10 ml placebo postoperative (Group A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 10 ml placebo preoperative, 10 μg/kg fentanyl + 10 ml placebo postoperative (Group C)
Number of subjects: 45
Study: 18445098

Group type: EXPERIMENTAL
Intervention: H. pylori screening and treatment
Number of subjects: 12530

Group type: COMPARATOR
Intervention: Control group (unscreened)
Number of subjects: 12530
Study: 16902311

Group type: EXPERIMENTAL
Intervention: Weekly or more frequent monitoring
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Regular access monitoring (performed by clinics)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Different vascular access monitoring practices
Number of subjects: 363
Study: 12499335

Group type: EXPERIMENTAL
Intervention: High dose of supplement (200 mg vitamin E, 300 mg vitamin C, 25 mg beta-carotene, 90 micro g Se, and 500 micro g vitamin A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low dose of supplement (10 mg vitamin E and 500 micro g vitamin A)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: High dose of supplement
Number of subjects: 46
Study: 11004144

Group type: EXPERIMENTAL
Intervention: On-pump conventional surgery with normothermic CPB and cardioplegic arrest
Number of subjects: 200

Group type: COMPARATOR
Intervention: Off-pump surgery on the beating heart
Number of subjects: 200
Study: 8695246

Group type: EXPERIMENTAL
Intervention: LH-RH analogue combined with a non-steroidal anti-androgen
Number of subjects: 63

Group type: COMPARATOR
Intervention: Orchiectomy
Number of subjects: 63
Study: 2003341

Group type: EXPERIMENTAL
Intervention: Ofloxacin taken orally once a day for three days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trimethoprim and sulfamethoxazole (TMP/SMX) taken orally twice a day for seven days
Number of subjects: 0
Study: 6663617

Group type: EXPERIMENTAL
Intervention: Preoperative tasks (walking, reaching, hand-eye coordination)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Eyeglass correction
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lens-implant or contact-lens correction
Number of subjects: 66
Study: 31187045

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome prevalence
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Risk factors for metabolic syndrome
Number of subjects: 405
Study: 28942334

Group type: EXPERIMENTAL
Intervention: 25-μg rhPTH(1‐84) daily dose
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 50-μg rhPTH(1‐84) daily dose
Number of subjects: 42
Study: 25671024

Group type: EXPERIMENTAL
Intervention: Hands-on training at 'Ultrafest' symposium
Number of subjects: 48
Study: 24379356

Group type: EXPERIMENTAL
Intervention: Surgical decompression of the tibial nerve
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control leg (no intervention)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Operated leg (surgical decompression)
Number of subjects: 42
Study: 22079995

Group type: EXPERIMENTAL
Intervention: Col diet (bovine colostrum)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Col‐6d diet (bovine colostrum for 6 days)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Col‐4d diet (bovine colostrum for 4 days)
Number of subjects: 832
Study: 18805726

Group type: EXPERIMENTAL
Intervention: Lumbopelvic joint manipulation
Number of subjects: 42

Group type: COMPARATOR
Intervention: 1 min lumbar passive range of motion (PROM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Prone extension on elbows for 3 min
Number of subjects: 42
Study: 17468682

Group type: EXPERIMENTAL
Intervention: Mood-congruent psychotic symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mood-incongruent psychotic symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both subtypes (mood-congruent and mood-incongruent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Efficacious treatment
Number of subjects: 0
Study: 15247729

Group type: EXPERIMENTAL
Intervention: Cook 12Fr Perc‐NCircle (38 cm)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Storz 3‐prong grasper (27090RB)
Number of subjects: 3
Study: 11305822

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 1 mg x kg(‐1) iv 30 min before surgery (PRE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 1 mg x kg(‐1) iv at the end of surgery (POST)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (CONT)
Number of subjects: 45
Study: 9228808

Group type: EXPERIMENTAL
Intervention: Short duration masker (10 ms)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Low-level standards with short duration masker and standard
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Second tone at 4.133 kHz presented simultaneously with the 1.0 kHz masker
Number of subjects: 4
Study: 7948340

Group type: EXPERIMENTAL
Intervention: Teacher-led smoking prevention program
Number of subjects: 2366

Group type: EXPERIMENTAL
Intervention: Peer-led smoking prevention program
Number of subjects: 2366
Study: 3598225

Group type: EXPERIMENTAL
Intervention: 100% of the standard im dose of HDCV
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 10% of the standard im dose of HDCV
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 3% of the standard im dose of HDCV
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 10% of the standard im dose id of HDCV
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 3% of the standard im dose id of HDCV
Number of subjects: 154
Study: 31396820

Group type: EXPERIMENTAL
Intervention: Consistent Tracking (≥6 out of 7 days for at least 75% of the targeted weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Consistent Tracking
Number of subjects: 100
Study: 28715806

Group type: EXPERIMENTAL
Intervention: Real-time volume contrast imaging in the A plane (VCI-A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional two-dimensional ultrasound (2D)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both VCI-A and 2D for malformed fetuses
Number of subjects: 100
Study: 26471432

Group type: EXPERIMENTAL
Intervention: Methylphenidate + Citalopram
Number of subjects: 35

Group type: COMPARATOR
Intervention: Citalopram + Placebo
Number of subjects: 35

Group type: COMPARATOR
Intervention: Methylphenidate + Placebo
Number of subjects: 35
Study: 25701333

Group type: EXPERIMENTAL
Intervention: Low AGE diet
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Exercise with habitual food intake
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Exercise plus low AGE diet
Number of subjects: 43
Study: 23818758

Group type: EXPERIMENTAL
Intervention: Higher-dose inhaled corticosteroids (ICS) in combination with long-acting beta-agonist (LABA) for one month, then shifted to guideline doses.
Number of subjects: 156

Group type: COMPARATOR
Intervention: Guideline doses (GD) therapy alone.
Number of subjects: 156
Study: 20524439

Group type: EXPERIMENTAL
Intervention: Ketotifen (0.5 mg or 1 mg orally twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Budesonide (200 microg inhaled twice daily)
Number of subjects: 30
Study: 19006630

Group type: EXPERIMENTAL
Intervention: Hospital-based pulmonary rehabilitation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Home pulmonary rehabilitation
Number of subjects: 51
Study: 16600723

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily for 24 months
Number of subjects: 2802

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 2802
Study: 12677572

Group type: EXPERIMENTAL
Intervention: TMP/SMZ (TMP 4 mg/kg/d and SMZ 20 mg/kg/d, divided in 2 doses)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Neomycin (25 mg/kg/d, qid, 4 days a week)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (historical control, no long-term prophylaxis)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: TMP/SMZ
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Neomycin
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: TMP/SMZ vs Neomycin
Number of subjects: 19
Study: 10958815

Group type: EXPERIMENTAL
Intervention: Whole‐meal rye bread
Number of subjects: 17

Group type: COMPARATOR
Intervention: White wheat bread
Number of subjects: 17
Study: 9066329

Group type: EXPERIMENTAL
Intervention: Cuffed endotracheal tubes sized by a new formula
Number of subjects: 488

Group type: COMPARATOR
Intervention: Uncuffed endotracheal tubes sized by the modified Cole's formula
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Cuffed endotracheal tubes
Number of subjects: 488

Group type: COMPARATOR
Intervention: Uncuffed endotracheal tubes
Number of subjects: 488
Study: 8373610

Group type: EXPERIMENTAL
Intervention: PGE1 (0.11 +/- 0.03 micrograms/kg/min) infusion
Number of subjects: 57

Group type: COMPARATOR
Intervention: Normotensive anesthesia
Number of subjects: 57
Study: 2942511

Group type: EXPERIMENTAL
Intervention: Mobilizing exercises
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Isometric exercises
Number of subjects: 36

Group type: COMPARATOR
Intervention: Attention-placebo control procedure
Number of subjects: 36
Study: 31288781

Group type: EXPERIMENTAL
Intervention: Customized exercise programs (CEPs) implemented by physical therapists
Number of subjects: 50

Group type: COMPARATOR
Intervention: Commonly prescribed exercises (Control)
Number of subjects: 50
Study: 27426276

Group type: EXPERIMENTAL
Intervention: Pramipexole (titrated from 0.09 to 0.54 mg, o.d., for 3 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 13
Study: 26474759

Group type: EXPERIMENTAL
Intervention: Toolkit presented in paper and electronic form, including a training webinar
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Toolkit plus in-person training with a focus on practice change and change management strategies
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Toolkit, in-person training, plus practice facilitation with on-site visits
Number of subjects: 29
Study: 23702394

Group type: EXPERIMENTAL
Intervention: Treadmill walking with handrail support
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overground walking with support
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Temporal gait parameters (stride time, symmetry index)
Number of subjects: 24
Study: 21672398

Group type: EXPERIMENTAL
Intervention: Policy change restricting sale of sugar-sweetened beverages in schools
Number of subjects: 2033

Group type: COMPARATOR
Intervention: National trends (NHANES)
Number of subjects: 2033
Study: 19670303

Group type: EXPERIMENTAL
Intervention: Paclitaxel stent
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Sirolimus stent
Number of subjects: 274

Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 274
Study: 17216435

Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg base daily for 3 days, then 250 mg weekly for 6 months)
Number of subjects: 1111
Study: 15161780

Group type: EXPERIMENTAL
Intervention: Multifaceted provider-level intervention (six monthly visits by a multidisciplinary health care team)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Multifaceted provider-level intervention
Number of subjects: 372

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 372
Study: 11394470

Group type: EXPERIMENTAL
Intervention: Compatible chord code (ECC) for inputting Chinese characters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomly mapped code for inputting Chinese characters
Number of subjects: 0
Study: 9738734

Group type: EXPERIMENTAL
Intervention: Pulsed nasal cannula delivery of nitric oxide (NO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Continuous mask delivery of nitric oxide (NO)
Number of subjects: 8
Study: 7986964

Group type: EXPERIMENTAL
Intervention: Torsemide 5 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Torsemide 10 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Torsemide 20 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 3192843

Group type: EXPERIMENTAL
Intervention: Dichloroacetate
Number of subjects: 18
Study: 8151005

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 358877

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study: 30689618

Group type: EXPERIMENTAL
Intervention: Light-emitting diode therapy (LEDT) applied to biceps brachii after strength training
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sham LEDT applied to biceps brachii after strength training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 45
Study: 25307829

Group type: EXPERIMENTAL
Intervention: Multidisciplinary group-based rehabilitation program with monthly motivational consultation
Number of subjects: 165

Group type: COMPARATOR
Intervention: Oral drug treatment alone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Multidisciplinary group-based rehabilitation program
Number of subjects: 165
Study: 25715157

Group type: EXPERIMENTAL
Intervention: CPS5‐TT/CPS8‐TT/AT/ClfA vaccine (5/5/10/10 μg or 10/10/30/30 μg dose with or without AS03B adjuvant)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 88
Study: 23265571

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 21333346

Group type: EXPERIMENTAL
Intervention: High-dose maintenance vaccine (4200 allergen units, approximately 70 μg of Der f 1/d)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low-dose maintenance vaccine (60 allergen units, approximately 1 μg of Der f 1/d)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 19833591

Group type: EXPERIMENTAL
Intervention: LAD revascularization first (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: RCA revascularization first (Group 2)
Number of subjects: 40
Study: 17560423

Group type: EXPERIMENTAL
Intervention: Prophylactic total colectomy for patients with chronic ulcerative colitis (UC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less invasive management options
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surveillance colonoscopy techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemoprevention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surveillance guidelines
Number of subjects: 0
Study: 14660478

Group type: EXPERIMENTAL
Intervention: Ribose (200 mg/kg body wt; Rib)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 8
Study: 11869160

Group type: EXPERIMENTAL
Intervention: Waking cervical spine pain and stiffness, headache, scapular or arm pain
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Waking headache
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Age effect on waking headache
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Waking cervical pain, stiffness, and headache in females
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Waking cervical pain, stiffness, and headache in males
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Waking with aching between the scapulae or in the arm
Number of subjects: 812
Study: 9822512

Group type: EXPERIMENTAL
Intervention: Clindamycin 900 mg every 8 hours and gentamicin 1.5 mg/kg every 8 hours until afebrile for a minimum of 24 hours (group 2)
Number of subjects: 116

Group type: COMPARATOR
Intervention: No scheduled postoperative antibiotics (group 1)
Number of subjects: 116
Study: 7853818

Group type: EXPERIMENTAL
Intervention: Gastrozepin treatment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ranisan treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (15 patients)
Number of subjects: 45
Study: 2912419

Group type: EXPERIMENTAL
Intervention: Fiberoptic catheter
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard pulmonary artery catheter
Number of subjects: 51
Study: 4597719

Group type: EXPERIMENTAL
Intervention: Cephapirin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 20
Study: 30841744

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy augmented with movement or occupational therapy (n=23)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Computerized cognitive training (n=27)
Number of subjects: 50
Study: 28625506

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: lixisenatide 20 μg
Number of subjects: 0